HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hongwei Gao Selected Research

Epidermal Growth Factor (EGF)

2/2022Cucurbitacin B inhibits TGF-β1-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hongwei Gao Research Topics

Disease

29Neoplasms (Cancer)
05/2024 - 10/2013
27Inflammation (Inflammations)
05/2023 - 07/2006
18Acute Lung Injury
01/2024 - 03/2005
16Sepsis (Septicemia)
10/2018 - 08/2003
12Infections
03/2024 - 10/2010
10Lung Neoplasms (Lung Cancer)
11/2023 - 01/2015
9Neoplasm Metastasis (Metastasis)
05/2024 - 10/2013
9Pneumonia (Pneumonitis)
01/2024 - 04/2005
9Lung Injury
01/2022 - 03/2005
7Necrosis
02/2024 - 06/2012
5Alzheimer Disease (Alzheimer's Disease)
10/2022 - 12/2017
5Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2017
4Osteosarcoma (Osteogenic Sarcoma)
02/2024 - 12/2014
4COVID-19
01/2022 - 03/2021
4Edema (Dropsy)
08/2021 - 11/2009
3Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 01/2016
3Breast Neoplasms (Breast Cancer)
01/2024 - 03/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2023 - 01/2021
3Pain (Aches)
03/2023 - 06/2012
3Type 2 Diabetes Mellitus (MODY)
01/2023 - 01/2018
3Hepatocellular Carcinoma (Hepatoma)
01/2023 - 11/2016
3Hemorrhage
01/2019 - 11/2009
3Bacterial Infections (Bacterial Infection)
11/2013 - 01/2009
2Carcinogenesis
04/2024 - 01/2023
2Myocardial Ischemia (Ischemic Heart Diseases)
04/2024 - 06/2021
2Liver Neoplasms (Liver Cancer)
11/2023 - 01/2019
2Myocardial Infarction
11/2023 - 04/2012
2Shock
07/2023 - 09/2017
2Virus Diseases (Viral Diseases)
01/2022 - 10/2010
2Atherosclerotic Plaque (Atheroma)
01/2022 - 01/2016
2Femoral Neck Fractures
02/2020 - 06/2012
2Body Weight (Weight, Body)
10/2019 - 07/2013
2Gastroesophageal Reflux (GERD)
05/2019 - 07/2018
2Bone Resorption
01/2019 - 01/2013

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
02/2024 - 03/2005
15CytokinesIBA
01/2023 - 07/2005
11Immunoglobulin G (IgG)IBA
01/2017 - 03/2005
9Antigen-Antibody Complex (Immune Complex)IBA
01/2017 - 03/2005
7Therapeutic UsesIBA
11/2023 - 10/2019
6Biomarkers (Surrogate Marker)IBA
04/2024 - 10/2013
6Interleukin-6 (Interleukin 6)IBA
11/2023 - 02/2004
6Eosine Yellowish-(YS) (Eosin)IBA
07/2023 - 01/2020
6Hematoxylin (Haematoxylon)IBA
07/2023 - 01/2020
6LipopolysaccharidesIBA
01/2022 - 04/2005
6CCAAT-Enhancer-Binding ProteinsIBA
01/2017 - 01/2012
5LipidsIBA
07/2023 - 11/2013
5EnzymesIBA
10/2022 - 10/2007
5MicroRNAs (MicroRNA)IBA
01/2019 - 10/2010
4Messenger RNA (mRNA)IBA
02/2024 - 12/2004
4InflammasomesIBA
10/2023 - 01/2020
4Xylenes (Xylene)IBA
08/2021 - 01/2017
4Phosphotransferases (Kinase)IBA
01/2020 - 11/2013
4ChemokinesIBA
06/2018 - 12/2004
4NF-kappa B (NF-kB)IBA
11/2017 - 08/2003
4Complement System Proteins (Complement)IBA
01/2012 - 01/2006
3RNA (Ribonucleic Acid)IBA
04/2024 - 01/2022
3AntioxidantsIBA
04/2024 - 01/2021
3Polysaccharides (Glycans)IBA
01/2024 - 04/2019
3anemoside B4IBA
01/2024 - 01/2020
3Peroxidase (Myeloperoxidase)IBA
11/2023 - 03/2005
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2015
3AcidsIBA
08/2020 - 07/2018
32-methoxy-6-acetyl-7-methyljugloneIBA
10/2019 - 03/2016
3Small Interfering RNA (siRNA)IBA
01/2019 - 11/2013
3AntibodiesIBA
12/2017 - 06/2005
3Anaphylatoxin C5a ReceptorIBA
01/2012 - 02/2004
2LY-2157299IBA
05/2024 - 01/2020
2oleuropeinIBA
04/2024 - 01/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2024 - 04/2022
2Antiviral Agents (Antivirals)IBA
01/2024 - 02/2021
2SaponinsIBA
01/2024 - 07/2023
2FlavonoidsIBA
11/2023 - 01/2017
2Malondialdehyde (Propanedial)IBA
11/2023 - 06/2021
2Superoxide DismutaseIBA
11/2023 - 06/2021
2LigandsIBA
09/2023 - 06/2018
2Gefitinib (Iressa)FDA Link
07/2023 - 01/2021
2Peptide Hydrolases (Proteases)FDA Link
03/2023 - 01/2006
2DNA (Deoxyribonucleic Acid)IBA
01/2023 - 10/2011
2cucurbitacin BIBA
02/2022 - 01/2021
2Immunoglobulin E (IgE)IBA
01/2022 - 01/2009
2Protein Kinases (Protein Kinase)IBA
01/2022 - 01/2020
2Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2020 - 01/2015
2theasinensin AIBA
01/2020 - 01/2019
2CalciumIBA
10/2019 - 01/2017
2Dipeptidyl-Peptidase IV InhibitorsIBA
08/2019 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2019 - 10/2016
2Long Noncoding RNAIBA
01/2019 - 08/2018
2Caspase 3 (Caspase-3)IBA
01/2019 - 01/2018
2resolvin D1IBA
10/2018 - 10/2014
2AlbuminsIBA
10/2018 - 03/2005
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2018 - 03/2016
2liriodendrinIBA
11/2017 - 10/2016

Therapy/Procedure

9Ligation
10/2018 - 02/2004
9Punctures
10/2018 - 02/2004
6Therapeutics
04/2024 - 04/2012
5Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2023 - 11/2017
4Drug Therapy (Chemotherapy)
04/2024 - 07/2010
2Immunotherapy
04/2024 - 01/2023
2Aftercare (After-Treatment)
02/2022 - 02/2020
2Intraperitoneal Injections
01/2022 - 10/2019